Arrowhead Stock Probability of Future Stock Price Finishing Over 33.05

ARWR
 Stock
  

USD 33.05  0.23  0.69%   

Arrowhead Pharma's future price is the expected price of Arrowhead Pharma instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Arrowhead Pharma performance during a given time horizon utilizing its historical volatility.
  
Arrowhead Pharma's implied volatility is one of the determining factors in the pricing options written on Arrowhead Pharma. Implied volatility approximates the future value of Arrowhead Pharma based on the option's current value. Options with high implied volatility have higher premiums and can be used to hedge the downside of investing in Arrowhead Pharma over a specific time period. For example, 2022-10-21 CALL at $35.0 is a CALL option contract on Arrowhead Pharma's common stock with a strick price of 35.0 expiring on 2022-10-21. The contract was last traded on 2022-09-30 at 12:24:26 for $2.08 and, as of today, has 19 days remaining before the expiration. The option is currently trading at a bid price of $0.55, and an ask price of $3.8. The implied volatility as of the 2nd of October is 92.4632. View All Arrowhead options

Closest to current price Arrowhead long CALL Option Payoff at Expiration

Please continue to Arrowhead Pharma Backtesting, Arrowhead Pharma Valuation, Arrowhead Pharma Correlation, Arrowhead Pharma Hype Analysis, Arrowhead Pharma Volatility, Arrowhead Pharma History as well as Arrowhead Pharma Performance. Please specify Arrowhead Pharma time horizon, a valid symbol (red box) and a target price (blue box) you would like Arrowhead Pharma odds to be computed.

Arrowhead Pharma Target Price Odds to finish over 33.05

The tendency of Arrowhead Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 33.05 90 days 33.05 
more than 94.0
Based on a normal probability distribution, the odds of Arrowhead Pharma to move above the current price in 90 days from now is more than 94.0 (This Arrowhead Pharma probability density function shows the probability of Arrowhead Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.9 . This suggests as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Arrowhead Pharma will likely underperform. Additionally The company has an alpha of 0.2162, implying that it can generate a 0.22 percent excess return over DOW after adjusting for the inherited market risk (beta).
   Arrowhead Pharma Price Density   
       Price  

Predictive Modules for Arrowhead Pharma

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arrowhead Pharma. Regardless of method or technology, however, to accurately forecast the stock or bond market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Arrowhead Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Arrowhead Pharma in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
29.7833.2836.78
Details
Intrinsic
Valuation
LowReal ValueHigh
29.9548.0551.55
Details
Naive
Forecast
LowNext ValueHigh
29.9233.4236.92
Details
7 Analysts
Consensus
LowTarget PriceHigh
45.0089.50106.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Arrowhead Pharma. Your research has to be compared to or analyzed against Arrowhead Pharma's peers to derive any actionable benefits. When done correctly, Arrowhead Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Arrowhead Pharma.

Arrowhead Pharma Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Arrowhead Pharma is not an exception. The market had few large corrections towards the Arrowhead Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arrowhead Pharma, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arrowhead Pharma within the framework of very fundamental risk indicators.
α
Alpha over DOW
0.22
β
Beta against DOW1.90
σ
Overall volatility
4.66
Ir
Information ratio 0.02958

Arrowhead Pharma Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arrowhead Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arrowhead Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Arrowhead Pharma generated a negative expected return over the last 90 days
Arrowhead Pharma has high historical volatility and very poor performance
Arrowhead Pharma is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 263.42 M. Net Loss for the year was (111.8 M) with profit before overhead, payroll, taxes, and interest of 138.29 M.
Arrowhead Pharma currently holds about 401.9 M in cash with (52.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.8.
Roughly 67.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Bona fide gift to Kenneth Myszkowski of 96676 shares of Arrowhead Pharma subject to Section 16

Arrowhead Pharma Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arrowhead Stock often depends not only on the future outlook of the current and potential Arrowhead Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arrowhead Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out4.66%
Short Percent Of Float5.44%
Float Shares102.82M
Shares Short Prior Month4.98M
Average Daily Volume Last 10 Day946.75k
Average Daily Volume In Three Month771.25k
Date Short Interest15th of July 2022

Arrowhead Pharma Technical Analysis

Arrowhead Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Arrowhead Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Arrowhead Pharma. In general, you should focus on analyzing Arrowhead Stock price patterns and their correlations with different microeconomic environments and drivers.

Arrowhead Pharma Predictive Forecast Models

Arrowhead Pharma time-series forecasting models is one of many Arrowhead Pharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Arrowhead Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Arrowhead Pharma

Checking the ongoing alerts about Arrowhead Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Arrowhead Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Arrowhead Pharma generated a negative expected return over the last 90 days
Arrowhead Pharma has high historical volatility and very poor performance
Arrowhead Pharma is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 263.42 M. Net Loss for the year was (111.8 M) with profit before overhead, payroll, taxes, and interest of 138.29 M.
Arrowhead Pharma currently holds about 401.9 M in cash with (52.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.8.
Roughly 67.0% of the company shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: Bona fide gift to Kenneth Myszkowski of 96676 shares of Arrowhead Pharma subject to Section 16
Please continue to Arrowhead Pharma Backtesting, Arrowhead Pharma Valuation, Arrowhead Pharma Correlation, Arrowhead Pharma Hype Analysis, Arrowhead Pharma Volatility, Arrowhead Pharma History as well as Arrowhead Pharma Performance. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Arrowhead Pharma price analysis, check to measure Arrowhead Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharma is operating at the current time. Most of Arrowhead Pharma's value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arrowhead Pharma's price. Additionally, you may evaluate how the addition of Arrowhead Pharma to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Arrowhead Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arrowhead Pharma. If investors know Arrowhead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arrowhead Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arrowhead Pharma is measured differently than its book value, which is the value of Arrowhead that is recorded on the company's balance sheet. Investors also form their own opinion of Arrowhead Pharma's value that differs from its market value or its book value, called intrinsic value, which is Arrowhead Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arrowhead Pharma's market value can be influenced by many factors that don't directly affect Arrowhead Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arrowhead Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arrowhead Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arrowhead Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.